ES355628A1 - Procedimiento para la estabilizacion de acido ascorcibo y sus derivados. - Google Patents

Procedimiento para la estabilizacion de acido ascorcibo y sus derivados.

Info

Publication number
ES355628A1
ES355628A1 ES355628A ES355628A ES355628A1 ES 355628 A1 ES355628 A1 ES 355628A1 ES 355628 A ES355628 A ES 355628A ES 355628 A ES355628 A ES 355628A ES 355628 A1 ES355628 A1 ES 355628A1
Authority
ES
Spain
Prior art keywords
ascorbic acid
particles
stabilization
derivatives
siloxane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES355628A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES355628A1 publication Critical patent/ES355628A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/06—Preparatory processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Paints Or Removers (AREA)
ES355628A 1967-06-30 1967-06-28 Procedimiento para la estabilizacion de acido ascorcibo y sus derivados. Expired ES355628A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH935967A CH509302A (de) 1967-06-30 1967-06-30 Verfahren zur Bildung eines Schutzüberzuges auf einzelnen Teilchen von Ascorbinsäure bzw. Isoascorbinsäure

Publications (1)

Publication Number Publication Date
ES355628A1 true ES355628A1 (es) 1969-12-16

Family

ID=4351152

Family Applications (1)

Application Number Title Priority Date Filing Date
ES355628A Expired ES355628A1 (es) 1967-06-30 1967-06-28 Procedimiento para la estabilizacion de acido ascorcibo y sus derivados.

Country Status (11)

Country Link
AT (1) AT279036B (it)
BE (1) BE717214A (it)
CH (1) CH509302A (it)
DE (2) DE1793234B1 (it)
DK (1) DK120503B (it)
ES (1) ES355628A1 (it)
FR (1) FR1600826A (it)
GB (1) GB1161289A (it)
IT (1) IT954021B (it)
NL (1) NL150792B (it)
SE (1) SE354185B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853741A (en) * 1996-06-28 1998-12-29 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Vitamin C delivery system
ZA971943B (en) * 1996-06-28 1998-09-07 Unilever Plc Vitamin C delivery system
US6087393A (en) * 1999-06-10 2000-07-11 Igen, Inc. Stabilized vitamin C formulations
FR3088345B1 (fr) 2018-11-08 2023-09-29 Max Sardou Procede de fabrication de fibres termostable a haute temperature
FR3105735B1 (fr) 2019-12-26 2023-07-07 Oreal Composition comprenant de l’acide ascorbique
FR3117847B1 (fr) 2020-12-18 2023-11-24 Oreal Composition comprenant des gélifiants aqueux, des tensioactifs et de l’acide ascorbique
FR3117803B1 (fr) 2020-12-18 2022-12-09 Oreal Composition comprenant des gélifiants aqueux, un tensioactif et de l’acide ascorbique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1051848B (de) * 1956-10-20 1959-03-05 Merck Ag E Verfahren zur Erhoehung der Bestaendigkeit von fester Ascorbinsaeure
NL296020A (it) * 1962-08-16

Also Published As

Publication number Publication date
DK120503B (da) 1971-06-07
IT954021B (it) 1973-08-30
NL150792B (nl) 1976-09-15
DE1300555B (de) 1969-08-07
FR1600826A (en) 1970-08-03
AT279036B (de) 1970-02-25
NL6808139A (it) 1968-12-31
DE1793234B1 (de) 1972-05-25
BE717214A (it) 1968-12-27
SE354185B (it) 1973-03-05
GB1161289A (en) 1969-08-13
CH509302A (de) 1971-06-30

Similar Documents

Publication Publication Date Title
IL35400A0 (en) Furoyl and thenoylphenoxy acetic acid derivatives,their preparation and pharmaceutical compositions containing them
ES413787A1 (es) Un metodo para preparar derivados de azucar de purina.
ES355628A1 (es) Procedimiento para la estabilizacion de acido ascorcibo y sus derivados.
IL30093A0 (en) Phosphoric acid esters,manufacture thereof and their use as insecticides
CA1023381A (en) Cyclic carboxylic acid derivatives
IL35659A0 (en) 9-azolylfluorene-9-carboxylic acid derivatives,their production and their use for the regulation of plant growth
FI49963C (fi) Menetelmä fosfaniilihapon ja 9-amino-3-nitroakridiinin antibakteerises ti vaikuttavien 1:1- ja 2:1-kompleksien valmistamiseksi.
IL35250A (en) 2-chloroethane-phosphonic and thionophosphonic acid derivatives,their preparation and their use for the regulation of plant growth
SE384511B (sv) 7-skyddad amino-delta?722?71-cefalosporansyraester, for anvendning som mellanforening vid framstellning av delta?723?71-cefalosporinantibiotika
IL35266A0 (en) New phosphoric acid esters,their production and their use as pesticides
ES368399A1 (es) Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilamino propanos sustituidos.
TR16617A (tr) 2,4-dioxo-1,3-benzoxazinothionophosphonic acid esters
ES337417A1 (es) Procedimiento para estabilizar etilenbisditiocarbamato man-ganoso.
CA774580A (en) Ascorbic acid esters, process for the manufacture thereof and use of same
FI49717C (fi) Menetelmä sepelvaltimoa laajentavien heterosyklisen renkaan hiileen al kyloitujen N,N'-disubstituoitujen diatsasykloalkaanien valmistamiseksi .
Balken et al. The" Shock" reaction in the Szondi Test.
AU415998B2 (en) Aminoalkyl esters, their acid addition salts isocyanato and isothiocyanato derivatives
CA806209A (en) Esters and their use as textile assistants
CA767648A (en) Derivatives of 3,5-diaminopyrazine-2,6-dicarboxylic acid
Rosic Acquisition of active avoidance behavior in rats by small doses of piperidyl-benzylates.
IL35116A0 (en) Phosphoric acid esters,their preparation and use as pesticides
AU1615467A (en) Aminoalkyl esters, their acid addition salts isocyanato and isothiocyanato derivatives
AU465502B2 (en) N, n-disubstituted-amino (thio) carboximidic esters and salts thereof, and their use as herbicides
FI42548C (fi) Förfarande för framställning av terapeutiskt värdefulla adamantan- och tricyklo£4,3,1,1yläviite3.8|-undekanderivat
CA820329A (en) Sulfur-containing derivatives of methylolated aminotriazines